BETTER LIVES BEGIN HERE
At Northern Bio, better lives begin with science. We are a team of passionate researchers driven by a common purpose: to develop treatments and cures for devastating diseases and improve human and animal health.
Innovative Treatments Begin With Us
Northern Bio is a preclinical CRO that specializes in targeted drug delivery, molecular biology, and bioanalysis to develop safe and effective treatments for devastating diseases. Using advanced surgical techniques and research, we maximize therapeutic impact. Collaboration and open communication are key to the strong partnerships we have with our sponsors. Committed to excellence, Northern Bio transforms possibilities into reality, paving the way for better lives through rigorous research and scientific advancement.
Advance Your Research With Us
Northern Bio specializes in preclinical research services, with expertise in in vivo non-GLP and GLP safety assessment solutions for novel therapeutics using advanced surgical techniques. Our Bioanalysis group focuses on advanced molecular biological techniques and ligand binding assays. We collaborate closely with our clients to develop customized preclinical studies to facilitate regulatory approval.
Committed to Animal Welfare
At Northern Bio, we are devoted to the welfare of the laboratory animals in our care. We have the utmost compassion and respect for our animals. The extensive training that our staff receives supports the unwavering dedication to the principle of the 3Rs (replacement, reduction, and refinement). This refined approach safeguards the quality of life of the animals and ensures the success of your study.
Change the World With Us
At Northern Bio, we’re not just conducting research; we’re changing the world, one experiment at a time. Join our team and contribute to groundbreaking research that has the power to transform lives.
Latest Blog Posts
qPCR and qRT-PCR analysis: Regulatory Points to Consider When Conducting Biodistribution and Vector Shedding Studies
Triplex RT-dPCR Method for a Safety Study in Drug Development
Route to a Safe Delivery Strategy of AAV-Based Gene Therapy to the Caudate and Putamen of Nonhuman Primates
SPK-10001 Induces a Durable and Safe Reduction of HTT Protein Supporting Further Development in Huntington’s Disease
Melanosis of the Dentate Nucleus in Two Cynomolgus Macaques
Discovery of a Novel C3-Targeting and CNS Active siRNA as a Potential Therapeutic for Alzheimer’s Disease
Upcoming Events
Biocom Global Partnering & Investor Conference
Biocom’s 16th Annual Global Life Science Partnering & Investor Conference is an exclusive global partnering and networking forum that brings together over 500 investors
2026 Rare Disease Day
The Rare Disease Network, in partnership with Calvin University, Corewell Health Helen DeVos Children’s Hospital, Michigan State University College of Human Medicine, Pine Rest
American College of Toxicology 47th Annual Meeting
The ACT 47th Annual Meeting will include a wide-ranging scientific program and educational courses, with distinguished plenary speakers, the popular Poster Session, an Awards
Upcoming Events
Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects
2026 Rare Disease Day
Biocom Global Partnering & Investor Conference
Partner With Us
Let’s work together to develop
life-changing treatments.
Join us in the pursuit of better lives through scientific innovation. Explore how Northern Bio can help you achieve your research goals.